Official UK procurement notice
NP40725 Erythropoietin Stimulating Agents
Authority: The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) (NHS & healthcare)
What is being bought
Published requirement descriptionSupply of Erythropoietin Stimulating Agents to NHS Scotland.
CPV: Pharmaceutical products
How this framework works
From the published notice- Places
- up to 4 suppliers · 3 bids received (0.8 per place) · 3 appointed
The lotProcurement structure
single lot · value publishedLot #1Supply of Erythropoietin Stimulating Agents to NHS ScotlandAwardedRenewalPublished value£8,550,215
Supply of Erythropoietin Stimulating Agents to NHS Scotland. The Authority intends to award this framework as a single supplier framework per line. Full details of Goods and volumes can be found within the ITT (Invitation to Tender) documents. Include further framework-specific content if appropriate.
What it takes to wini
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Evaluation split and conditions of participation as published; the tender pack may add morei
How this buyer will score bids.
The evaluation criteria and weights exactly as published on the notice, grouped by family (price, quality, social value and so on).
Published sub-criteria (2)
- Supply Chain: 5%
- price: 95%
Published award criteria (2)
- Supply Chain: 5
- Price: 95
- Suitability
Contract Notice for Goods- Economic operators may be excluded from this competition if they are in breach of any situation referred to in regulation 58 of the Public Contracts (Scotland) Regulations 2015
- Technical & professional ability
(a) Potential Framework Participants must be able to demonstrate the existence of a valid and current UK Marketing Authorisation (PL, PLGB, or PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender/start date of the Framework Agreement.
(b) Potential Framework Participants and any sub-contractor(s) must possess valid certification of BS EN ISO 9001 or equivalent.
(c) All tendered Goods must comply with the MHRA best Practice Guidance on Labelling and Packaging and the National Patient Safety Agency ("NPSA") Guidelines on Packaging and Labelling on pack design.
(d) Potential Framework Participants are required to provide evidence that their organisation has taken steps to build their awareness of the climate change emergency and how they will respond.
Minimum: (a) Confirmation of existence of a valid and current UK Marketing Authorisation (PL, PLGB, PLPI number) that has been approved by the MHRA for all tendered Medicines at the date of submission of the tender/start date of the Framework Agreement should be included in the Qualificat…
- Price carries 95 of 100 points: a 10% discount moves about 9.5 points. This one is won on the number: sharpen the price before polishing the prose.
- “NP40725 Erythropoietin Stimulating Agents” is a framework: the contest is a place on its panel, up to 4 suppliers, not a single contract.
Price arithmetic assumes straight proportional scoring; the tender pack may use another formula.
Procedure terms & legal framework
From the official record · publisher note attached- Procedure method
- Open procedure
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Framework agreement
- Who may use this agreement
- Not stated in the notice; call-off rights may be limited to the establishing authority
- Competition type
- Competitive procedure
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- No (one-off requirement)
- First published
- 31 Jul 2025, 14:19 BST
- Last source update
- 19 Nov 2025, 14:34 GMT
- Award evaluation window
- 1 Sept 2025 – …
- FTS notice number
2025/S 000-075277- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-056a43Find a Tender
- Electronic trading
- e-invoicing allowed · electronic ordering · electronic payment
- Review procedure
The Authority will notify economic operators who submitted a tender or (where no deselection notification has previously been made) applied to be selected to tender, of its decision to award the framework agreement which notification will contain among other information, a summary of the reasons why the economic operators was unsuccessful. The notification will incorporate a ‘standstill period’ of a minimum of 10 clear calendar days (or a minimum of 15 if the communication method used is not electronic) between the date on which the Authority dispatches the notice(s) and the date on which the Authority proposes to conclude the relevant framework agreement. The bringing of court proceedings against the Authority during the standstill period will automatically continue the prohibition on entering into the framework agreement until the court proceedings are determined, discontinued, or disposed of, or the court, by interim order, brings to an end the prohibition. The remedies that may be awarded by the courts before the framework agreement has been entered into include the setting aside of the decision to award the framework agreement to the winning tenderer(s). The bringing of court proceedings against the Authority after the framework agreement has been entered into will not affect the framework agreement unless grounds for the imposition of special penalties under the Public Contracts (Scotland) Regulations 2015 can be established. Otherwise, the remedies that may be awarded by the courts where the framework agreement has been entered into are limited to the award of damages.
Publisher note: The estimated value(s) referred to in Section II.1.7 and V.2.4 cover(s) the thirty-six (36) month contract duration and the twelve (12) month extension period of the framework agreement. (SC Ref:816001)
How it was run
Official notice- Appointment period ends
- 1 Sept 2025, 17:00 BST
- Submission channel
- {"electronicSubmission"}
- Accepted languages
- en
- Bid validity
- 90 days from the deadline
- Bids opened
- 1 Sept 2025, 17:00 BST
Timeline
1 Sept 2025 → 19 Nov 2025 · 3 dates- Admission / appointment period endsperiod end, not a bid countdown1 Sept 2025, 17:00 BST
- Bids opened1 Sept 2025, 17:00 BST
- Notice published338 days ago19 Nov 2025, 14:34 GMT
Notice history
1 event · 2 releases on Find a Tender- Status changed to complete19 Nov 2025, 14:34 GMT
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecast1 suppliers are admitted to this framework without individual award values or dates, see the supplier list below.
Contracts
Contract 075277-2025-1
- Signed
- 28 Oct 2025
- Value
- £8,493,876
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 3bids · 3 electronic · 3 from abroad | 0 | — | — |
Contracting authority & participating public bodies
Dispute resolution & review bodies
- Sheriff Court HouseReview body
Framework contractors & participating bidders
3 commercial parties on the notice- Amgen LtdFramework contractor
- PfizerFramework contractor
- Roche Products LtdFramework contractor
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.